Research analysts covering Drugs Made In America Acquisition II.
Recent press releases and 8-K filings for DMII.
Drugs Made In America Acquisition II Corp. Completes IPO and Private Placement
DMII
M&A
New Projects/Investments
- Drugs Made In America Acquisition II Corp. (DMII) consummated its initial public offering (IPO) of 50,000,000 units at $10.00 per unit, generating $500,000,000 in gross proceeds on September 26, 2025.
- Simultaneously, the company completed a private placement of 1,200,000 units at $10.00 per unit, raising an additional $12,000,000.
- As of September 26, 2025, $500,000,000 of the net proceeds from the IPO and private placement were deposited into a trust account for the benefit of public shareholders.
- The company, a blank check company incorporated on August 23, 2024, intends to focus on the pharmaceutical industry for its business combination and has 24 months from the IPO closing to complete it.
- The independent registered public accounting firm, MaloneBailey, LLP, issued an opinion on the financial statements that included a going concern matter due to the company's reliance on completing a business combination within a prescribed period.
Oct 2, 2025, 9:15 PM
Drugs Made In America Acquisition II Corp. Announces IPO Pricing and Closing
DMII
Delisting/Listing Issues
- Drugs Made In America Acquisition II Corp. (DMII) priced its initial public offering of 50,000,000 units at $10.00 per unit on September 25, 2025.
- The IPO closed on September 26, 2025, generating $500,000,000 in gross proceeds before deducting underwriting discounts and offering expenses.
- Concurrently with the IPO closing, the company closed a private placement of 1,200,000 private placement units at $10.00 per unit, resulting in gross proceeds of $12,000,000.
- A total of $500,000,000 from the proceeds of the initial public offering and the private placement has been deposited into a trust account.
- The units began trading on The Nasdaq Global Market under the ticker symbol DMIIU on September 25, 2025.
Sep 29, 2025, 9:28 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more